STUDY ON CO-MORBIDITIES IN PATIENTS WITH TYPE II DIABETES MELLITUS

Author(s)

Khatri B
Acharya and BM Reddy College of Pharmacy, Bangalore, India

OBJECTIVES: Study of co-morbidities in patients with type II diabetes mellitus is important as co-morbidities increase the disease burden and cost. It results in poor quality of life and reduced life expectancy. Studies have shown that diabetes is associated with different diseases such as hypertension, cardiovascular diseases, chronic kidney disease, dyslipidemia, tuberculosis, anemia, depression etc. METHODS: The study was of prospective and observational type. It was conducted in a teaching hospital in South India for a period of 5 months from July 2016 to November 2016. All the patients diagnosed with type II diabetes mellitus with medical history of it since more than 1 year were included in the study. RESULTS: Out of the total 62 patients, majority (56%) were males. The median age was 52. Majority of the patients (27%) had a single co-morbidity, 18% had two co-morbidities and very few patients had three or more co-morbidities. Hypertension (38%) was the most common co-morbidity. Other co-morbidities found were cardiovascular diseases (11%), chronic kidney disease (9%), depression (6%), tuberculosis (6%), anemia (4%) hypothyroidism (3%) etc. CONCLUSIONS: Co-morbidities were common in patients with type II diabetes mellitus. Proper selection of antidiabetic drugs considering co-morbidities can provide better outcome and prevent further complications in patients.

Conference/Value in Health Info

2017-05, ISPOR 2017, Boston, MA, USA

Value in Health, Vol. 20, No. 5 (May 2017)

Code

PDB5

Topic

Epidemiology & Public Health

Topic Subcategory

Safety & Pharmacoepidemiology

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×